TruAlt Bioenergy Q4 FY26 earnings call transcript filed

Mgmt Guided Margin ImprovementMgmt Guided Margin PressureOrder Pipeline DisclosedInvestor Communications View source PDF

TRUALT · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

+0.5%1-day move

₹493.00

prior close

₹497.00

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

+1.2+1.9+2.4+3.4+0.5+3.2+1.6+2.4+2.8+8.0-0.6-7.1——

Up moveDown movePending

AI summary

TruAlt Bioenergy filed Q4/FY26 earnings call transcript. Revenue fell 8.6% to ₹1,704 Cr on lower ethanol allocation. EBITDA margin improved to 19.81% from 18.98%, but PAT dropped to ₹80.26 Cr (vs ₹140 Cr) as depreciation rose 30% and finance costs 12% on dual-feed plant capitalization. Pending 15 Cr litre ethanol court order, CBG expansion to 162 TPD via Sumitomo/GAIL JVs, SAF plans with Honeywell UOP. Targeting 87 fuel outlets.

Likely market impact

Mixed: margin gains offset by earnings dip from higher depreciation. Growth hinges on ethanol court order and CBG/SAF expansion timelines.